FDA Approved: FLUOROURACIL — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluorouracil submitted by Taro Pharmaceuticals U.S.A., Inc., approving changes to the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)

Snippet

SUPPL AP for FLUOROURACIL (FLUOROURACIL)